Tg Therapeutics (TGTX) Raw Materials (2023 - 2025)

Tg Therapeutics' Raw Materials history runs 3 years deep, the most recent figure standing at $4.1 million for Q3 2025.

• In Q3 2025, Raw Materials rose 134.08% year-over-year to $4.1 million; the TTM figure through Sep 2025 stood at $4.1 million (up 134.08% YoY), while the FY2024 annual figure was $28.2 million, up 327.7% from the prior year.
• Raw Materials was $4.1 million for Q3 2025 at Tg Therapeutics, down from $4.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $28.2 million in Q4 2024 to a low of $24000.0 in Q1 2023.
• Historically, Raw Materials has averaged $4.9 million across 3 years, with a median of $1.7 million in 2024.
• Biggest YoY gain for Raw Materials was 7129.17% in 2024; the steepest drop was 41.21% in 2024.
• A 3-year view of Raw Materials shows it stood at $6.6 million in 2023, then soared by 327.7% to $28.2 million in 2024, then tumbled by 85.58% to $4.1 million in 2025.
• The last three Raw Materials figures came in at $4.1 million (Q3 2025), $4.1 million (Q2 2025), and $4.1 million (Q1 2025), per Business Quant data.